Tracy Rasmussen
Primary Care · Parker, CONPI 1871371096
Payments from drug & device makers
What this record shows
Almost everything reported here is food and beverage — 100.0% of the total across 184 separate payments, which is the pattern of a clinician who attends manufacturer presentations rather than one with a consulting arrangement. It is spread thinly across 34 manufacturers, the largest accounting for just 18.5% — the pattern of someone who eats at a lot of different presentations. Among primary care clinicians in CO with any reported payments, this total sits in the top 5% — high for the specialty, which is a reason to read the composition above rather than the number alone.
Across 184 payments — averaging $23.21 each. Meals, travel, consulting and speaking fees, gifts and royalties reported by drug and device makers.
- AstraZeneca$789
- Novo Nordisk$470
- AbbVie$420
- Pfizer$294
- Lundbeck LLC$235
- ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.)$229
- plus $2K from 28 others
What the payments were for
- Food & beverage$4,270100%
Most of this is food and beverage — typically meals provided during product presentations at a clinic or hospital. Nationally that is the single largest category of reported payments by count.
General payments by program year
Who reported the general payments
Companies are grouped under their corporate parent — a single manufacturer often files under several CMS reporting entities. Research and ownership payments are counted separately and are not in this table.
| Company | Payments | Total |
|---|---|---|
| AstraZeneca | 24 | $789 |
| Novo Nordisk | 22 | $470 |
| AbbVie | 18 | $420 |
| Pfizer | 15 | $294 |
| Lundbeck LLC | 12 | $235 |
| ITI, Inc. (d/b/a Intra-cellular Therapies, Inc.) | 9 | $229 |
| Otsuka America Pharmaceutical, Inc. | 8 | $181 |
| Medtronic | 1 | $147 |
| Corium, LLC | 14 | $134 |
| Lilly USA, LLC | 7 | $119 |
| Vanda Pharmaceuticals Inc. | 4 | $115 |
| Takeda Pharmaceuticals U.S.A., Inc. | 4 | $95 |
| Axsome Therapeutics, Inc. | 4 | $92 |
| Tris Pharma Inc | 2 | $88 |
| Collegium Pharmaceutical, Inc. | 5 | $84 |
| Exact Sciences | 3 | $74 |
| Astellas Pharma US Inc | 3 | $73 |
| Bayer | 3 | $71 |
| Organon | 2 | $55 |
| Vertical Pharmaceuticals, LLC | 3 | $48 |
| Aimmune Therapeutics, Inc. | 2 | $46 |
| Corcept Therapeutics | 2 | $45 |
| Alkermes, Inc. | 2 | $44 |
| Exeltis, USA Inc. | 2 | $44 |
| Amgen | 2 | $40 |
| Shield Therapeutics Inc | 1 | $39 |
| Idorsia Pharmaceuticals US Inc | 2 | $39 |
| Paratek Pharmaceuticals, Inc. | 2 | $37 |
| Seqirus USA Inc | 1 | $26 |
| Teva Pharmaceuticals USA, Inc. | 1 | $26 |
| Ironshore Pharmaceuticals Inc. | 1 | $19 |
| Esperion Therapeutics, Inc. | 1 | $19 |
| Phadia US Inc. | 1 | $16 |
| Optinose US, Inc. | 1 | $15 |
What the payments were tied to
Products named in the reported payments. Only payments of $100 or more are attributed here — the typical reported payment nationally is a meal worth about $16, and listing those product-by-product would be noise.
- FARXIGA$354
- AIRSUPRA$191
- COREVALVE EVOLUT R$147
- Wegovy$122
How this compares
$4,270 in reported general payments places this provider in the 95th percentile of 112 primary care providers in Colorado.
Most prescribed under Part D
| Drug | Claims | Cost to plans & patients |
|---|---|---|
| ProgesteroneProgesterone, Micronized | 12 | $762 |
| Liothyronine Sodium | 17 | $592 |
| Levothyroxine Sodium | 21 | $181 |
| Gabapentin | 14 | $166 |
| Losartan Potassium | 18 | $143 |
| Ondansetron OdtOndansetron | 11 | $137 |
| Lamotrigine | 12 | $121 |
| Atorvastatin Calcium | 13 | $90 |
| Metformin Hcl ErMetformin Hcl | 20 | $82 |
Paid to pharmacies, not to this prescriber.
Other primary care in Parker
- Lisa HammondParker$1K
- Laura CarlsenLittleton$22K
- Kendra PayneCastle Rock$22K
- Kaitlin KrausDenver$16K
- Emily WillmannThornton$4K
- Linda MyersGrand Junction$4K
- Kathryn PalmerGreeley$4K
- Leah BrownFort Morgan$3K
- Diana Rodriguez OrtizAurora$2K
- Amanda FadenrechtPueblo West$2K
Where these figures come from
- Payments: CMS Open Payments, program years 2019–2025 (publication P06302026_06032026).
- Identity: NPPES NPI Registry, July 2026.